BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17184797)

  • 1. The shape of things to come: structural and synthetic studies of taxol and related compounds.
    Kingston DG
    Phytochemistry; 2007 Jul; 68(14):1844-54. PubMed ID: 17184797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".
    Yang Y; Alcaraz AA; Snyder JP
    J Nat Prod; 2009 Mar; 72(3):422-9. PubMed ID: 19267457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of simplified taxol analogs based on the T-Taxol bioactive conformation.
    Zhao J; Bane S; Snyder JP; Hu H; Mukherjee K; Slebodnick C; Kingston DG
    Bioorg Med Chem; 2011 Dec; 19(24):7664-78. PubMed ID: 22071526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging converts a noncytotoxic nor-paclitaxel derivative to a cytotoxic analogue by constraining it to the T-Taxol conformation.
    Tang S; Yang C; Brodie P; Bane S; Ravindra R; Sharma S; Jiang Y; Snyder JP; Kingston DG
    Org Lett; 2006 Aug; 8(18):3983-6. PubMed ID: 16928054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.
    Snyder JP; Nettles JH; Cornett B; Downing KH; Nogales E
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5312-6. PubMed ID: 11309480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.
    Ganesh T; Yang C; Norris A; Glass T; Bane S; Ravindra R; Banerjee A; Metaferia B; Thomas SL; Giannakakou P; Alcaraz AA; Lakdawala AS; Snyder JP; Kingston DG
    J Med Chem; 2007 Feb; 50(4):713-25. PubMed ID: 17263521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
    Kingston DG; Chaudhary AG; Chordia MD; Gharpure M; Gunatilaka AA; Higgs PI; Rimoldi JM; Samala L; Jagtap PG; Giannakakou P; Jiang YQ; Lin CM; Hamel E; Long BH; Fairchild CR; Johnston KA
    J Med Chem; 1998 Sep; 41(19):3715-26. PubMed ID: 9733497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and bioactivity of a side chain bridged paclitaxel: A test of the T-Taxol conformation.
    Hodge M; Chen QH; Bane S; Sharma S; Loew M; Banerjee A; Alcaraz AA; Snyder JP; Kingston DG
    Bioorg Med Chem Lett; 2009 May; 19(10):2884-7. PubMed ID: 19359169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of Taxol and Taxotere analogues.
    Guénard D; Guéritte-Voegelein F; Dubois J; Potier P
    J Natl Cancer Inst Monogr; 1993; (15):79-82. PubMed ID: 7912533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oxetane ring in taxol.
    Wang M; Cornett B; Nettles J; Liotta DC; Snyder JP
    J Org Chem; 2000 Feb; 65(4):1059-68. PubMed ID: 10814054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and NMR-driven conformational analysis of taxol analogues conformationally constrained on the C13 side chain.
    Barboni L; Lambertucci C; Appendino G; Vander Velde DG; Himes RH; Bombardelli E; Wang M; Snyder JP
    J Med Chem; 2001 May; 44(10):1576-87. PubMed ID: 11334567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of de novo cytotoxic alkaloids by mimicking the bioactive conformation of paclitaxel.
    Sun L; Veith JM; Pera P; Bernacki RJ; Ojima I
    Bioorg Med Chem; 2010 Oct; 18(19):7101-12. PubMed ID: 20800500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ.
    Rice A; Liu Y; Michaelis ML; Himes RH; Georg GI; Audus KL
    J Med Chem; 2005 Feb; 48(3):832-8. PubMed ID: 15689167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-Taxol bioactive conformation.
    Ganesh T; Norris A; Sharma S; Bane S; Alcaraz AA; Snyder JP; Kingston DG
    Bioorg Med Chem; 2006 May; 14(10):3447-54. PubMed ID: 16434198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotational-echo double-resonance NMR distance measurements for the tubulin-bound Paclitaxel conformation.
    Paik Y; Yang C; Metaferia B; Tang S; Bane S; Ravindra R; Shanker N; Alcaraz AA; Johnson SA; Schaefer J; O'Connor RD; Cegelski L; Snyder JP; Kingston DG
    J Am Chem Soc; 2007 Jan; 129(2):361-70. PubMed ID: 17212416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-tubulin activity of a 3'-(4-azidophenyl)-3'-dephenylpaclitaxel photoaffinity probe.
    Spletstoser JT; Flaherty PT; Himes RH; Georg GI
    J Med Chem; 2004 Dec; 47(26):6459-65. PubMed ID: 15588080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design.
    Geney R; Sun L; Pera P; Bernacki RJ; Xia S; Horwitz SB; Simmerling CL; Ojima I
    Chem Biol; 2005 Mar; 12(3):339-48. PubMed ID: 15797218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the aromatic rings of taxol on biological activity and solution conformation: synthesis and evaluation of saturated taxol and taxotere analogues.
    Boge TC; Himes RH; Vander Velde DG; Georg GI
    J Med Chem; 1994 Sep; 37(20):3337-43. PubMed ID: 7932561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological activity of protaxols.
    Nicolaou KC; Riemer C; Kerr MA; Rideout D; Wrasidlo W
    Nature; 1993 Jul; 364(6436):464-6. PubMed ID: 8101355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel macrocyclic docetaxel analogues. Influence of their macrocyclic ring size on tubulin activity.
    Querolle O; Dubois J; Thoret S; Roussi F; Montiel-Smith S; Guéritte F; Guénard D
    J Med Chem; 2003 Aug; 46(17):3623-30. PubMed ID: 12904066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.